D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review - Wikidata - wikimedia - TriplyDB

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

http://www.wikidata.org/entity/Q26781321

about

A randomized placebo-controlled pilot study of the efficacy and safety of D-cycloserine in people with chronic back pain.Autoimmune Encephalitis: An Expanding Frontier of Neuroimmunology A review on comparative mechanistic studies of antimicrobial peptides against archaea.Do specific NMDA receptor subunits act as gateways for addictive behaviors?Adverse effects of oral second-line antituberculosis drugs in children.Neuropsychiatric Effects of Antimicrobial Agents.Identification of AICP as a GluN2C-Selective N-Methyl-d-Aspartate Receptor Superagonist at the GluN1 Glycine Site.Autoimmune phenotypes in schizophrenia reveal novel treatment targets.

P2860

Q30275402-9CBC93C9-73CE-4B09-A197-8ADF96972EB3 Q36856592-1D1DC0F8-2586-4FE3-A7D9-64FA4FBB3AD4 Q38653377-BAA06EB8-6AB7-41BF-A0FA-38CDDFB0952D Q38814541-48442708-D20C-4787-8161-C2DF562F4A64 Q38837774-84273583-5408-4BB4-A542-320BEF0F5D4F Q39135986-AEC14094-AEEA-4D86-BCC2-41627B3BC2C9 Q50956250-5457DC80-1430-4CD6-8104-CC599BEFB139 Q54217096-CB274850-C824-4D5B-99AF-30FCC77F0113

P2860

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

http://www.wikidata.org/entity/Q26781321

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@ast

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@en

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@nl

type

label

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@ast

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@en

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@nl

prefLabel

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@ast

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@en

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@nl

P1433

Q26781321-D6ACAB9F-2A12-4F52-BF0D-F430F6CE5757

P1476

Q26781321-23600109-0BDA-43BC-9DE6-3A2708EF073A

P2093

Q26781321-13D9208B-464C-4225-B23F-3EED5E782A70

P275

Q26781321-3EE11DBA-9FD8-483B-BDDE-7A43D88F12A6

P2860

Q26781321-000C8EF2-8382-4C2D-BA36-7B054ED301B1

Q26781321-00AD8E2F-D050-4906-A718-1B4E002E4FDB

Q26781321-02B51C67-A716-44BB-B3EC-844078BFA414

Q26781321-061D67A0-B88B-4416-8C92-D3E5C4A14A05

Q26781321-0693A6C1-72DC-441F-84EE-3CDA51383E43

Q26781321-07646FD6-CBE3-4BFB-A299-9DB361BEB27C

Q26781321-0A28176B-EC74-4358-A18C-80CAC41E1A84

Q26781321-136F0114-0E2A-490D-A6F4-2B5306812B0B

Q26781321-14E7AB7F-8428-4404-B41C-12CECB829242

Q26781321-18732F1D-2431-42F2-84E4-94A77345B998

P304

Q26781321-47C5611D-8FF9-4A3A-9C4A-AFF12997EF29

P31

Q26781321-3A213EF0-972F-4126-8C17-3E635C3D6C5D

Q26781321-B98537FA-488F-483D-8B93-FCB7DA2959E0

Q26781321-CE505550-6A0E-44CB-9AB9-122BC15AF39D

P356

Q26781321-9468D86B-3E8E-4693-8320-2767E9CCDFEC

P407

Q26781321-AFBE81EE-4C06-4F46-9486-B7F42D6329C8

P433

Q26781321-F37E640A-36AB-4316-9A4A-20EDE1459607

P478

Q26781321-27BE019E-9CCC-403D-BDCE-ED60319972CB

P50

Q26781321-E8459A51-371B-481B-A76B-DF3DA61B6B0C

P5008

Q26781321-CC364D97-48E0-4D40-B49C-69823237B718

P577

Q26781321-2BC8E550-AE7B-4E1F-81E5-01749585B6F1

Q26781321-F41C0C8A-D103-4BD6-B47F-8379EF0DB435

P5875

Q26781321-C1E65165-BCA3-4AA2-9B96-790ACD732226

P698

Q26781321-BC845E31-DC6C-4C78-8902-A98C0FAC0C0B

P921

Q26781321-04A03D8C-C3B4-432F-883C-D6DBE5D9733D

Q26781321-1606869B-B7CA-45CB-98D7-5C1B2ABF4F83

Q26781321-76EB92D3-6998-4F3E-985B-77FC771C57C4

Q26781321-7F353A02-4A49-4F23-9C7F-FDBC9C7C33F9

Q26781321-9EEF51E2-2943-4754-9879-F7E0472FF7C7

Q26781321-A576B7DF-9E96-4E5D-BD9C-32D5F886E8AE

Q26781321-BA12113B-32DC-4DDA-B91C-98482CED1BF7

Q26781321-D29AF074-591A-4597-895F-A01926A12BDA

P932

Q26781321-BFD06BB7-9F1E-4CC5-A46D-2DC9C13E6134

P356

P1433

The International Journal of Neuropsychopharmacology

P1476

D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review

@en

P2093

Walter Paulus

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis

NMDA receptors and fear extinction: implications for cognitive behavioral therapy

Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders

D-cycloserine effects on extinction of conditioned responses to drug-related cues

Consolidation of human motor cortical neuroplasticity by D-cycloserine

Behavioral analysis of NR2C knockout mouse reveals deficit in acquisition of conditioned fear and working memory.

D-cycloserine and cocaine cue reactivity: preliminary findings.

D-cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window.

Sleep quality predicts treatment outcome in CBT for social anxiety disorder.

Combining d-cycloserine with motor training does not result in improved general motor learning in neurologically intact people or in people with stroke.

P304

pyv102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

systematic review

P356

10.1093/IJNP/PYV102

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Sebastian Schade

P5008

P577

2016-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283037517

http://www.w3.org/2001/XMLSchema#string

P698

26364274

http://www.w3.org/2001/XMLSchema#string

P921

mental disorder

heterocyclic compound

transport protein

cell surface receptor

mechanism of action

neurological disorder

membrane proteins

P932

4851259

http://www.w3.org/2001/XMLSchema#string